Kallyope

About:

Kallyope uses the science of gut-brain biology to create medicines that transform human health.

Website: http://www.kallyope.com

Top Investors: StepStone Group, Bill & Melinda Gates Foundation, Lux Capital, Alexandria Venture Investments, Two Sigma Ventures

Description:

Kallyope is pioneering the science and understanding of gut and gut-brain biology to create medicines that transform human health. Based in New York City, Kallyope is home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development. Kallyope leverages a unique combination of leading technologies and a foundation of internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health – from diabetes, obesity, and gut disorders to inflammatory disease, migraine, allergies, and more.

Total Funding Amount:

$487M

Headquarters Location:

New York, New York, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)kallyope.com

Founders:

Charles Zuker, Richard Axel, Tom Maniatis

Number of Employees:

51-100

Last Funding Date:

2023-05-10

IPO Status:

Private

© 2025 bioDAO.ai